Maven Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,983
| Closed | -$558K | – | 310 |
|
|
2025
Q1 | $558K | Buy |
+4,983
| New | +$558K | 0.02% | 167 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 394 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 408 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 381 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 406 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 363 |
|
|
2023
Q3 | – | Sell |
-6,580
| Closed | -$507K | – | 412 |
|
|
2023
Q2 | $507K | Buy |
+6,580
| New | +$507K | 0.01% | 170 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 340 |
|
|
2022
Q4 | – | Sell |
-14,539
| Closed | -$897K | – | 342 |
|
|
2022
Q3 | $897K | Buy |
+14,539
| New | +$897K | 0.02% | 203 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 425 |
|
|
2022
Q1 | – | Sell |
-3,503
| Closed | -$254K | – | 455 |
|
|
2021
Q4 | $254K | Buy |
+3,503
| New | +$254K | 0.01% | 293 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 639 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 776 |
|
|
2021
Q1 | – | Sell |
-20,269
| Closed | -$1.18M | – | 882 |
|
|
2020
Q4 | $1.18M | Buy |
20,269
+4,756
| +31% | +$277K | 0.12% | 200 |
|
|
2020
Q3 | $974K | Buy |
15,513
+9,132
| +143% | +$573K | 0.08% | 162 |
|
|
2020
Q2 | $491K | Buy |
+6,381
| New | +$491K | 0.03% | 132 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 192 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 212 |
|
|
2017
Q1 | – | Sell |
-476
| Closed | -$34K | – | 53 |
|
|
2016
Q4 | $34K | Buy |
+476
| New | +$34K | 0.03% | 38 |
|